Showing results (21-30 of 131) with videos related to
Sort By:
Pageof 14
BMC Pregnancy and Childbirth|June 19, 2026
Pre-hospital healthcare for hyperemesis gravidarum: a cross-sectional analysis of baseline data from the SUKK-P studyHilde Erdal, Jone Trovik, Kristine Heitmann, et al.Cancer Letters|November 7, 2017
Long non-coding RNA HAND2-AS1 inhibits invasion and metastasis in endometrioid endometrial carcinoma through inactivating neuromedin UXueying Yang, Chi Chiu Wang, Wayne Yuk Wai Lee, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2011
The role of adjuvant chemotherapy in surgical stages I-II serous and clear cell carcinomas and carcinosarcoma of the endometrium: a collaborative studyIngrid Vandenput, Jone Trovik, Ignace Vergote, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2011
Elevated plasma growth differentiation factor-15 correlates with lymph node metastases and poor survival in endometrial cancerAnne Cathrine Staff, Jone Trovik, Ane Gerda Zahl Eriksson, et al.Ebiomedicine|May 5, 2023
Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent diseaseHilde E Lien, Hege F Berg, Mari K Halle, et al.Gynecologic Oncology|July 7, 2009
Plasma calprotectin concentrations in women with endometrial carcinomaHannah Ni Bhriain, Jone Trovik, Elisabeth Wik, et al.European Radiology|February 9, 2020
Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancerKristine E Fasmer, Ankush Gulati, Julie A Dybvik, et al.Plos One|January 16, 2019
Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancerHilde Engerud, Kirsten Hope, Hege Fredriksen Berg, et al.BJC Reports|April 15, 2026
High expression of the ADC target Claudin-6 associates with aggressive endometrial cancer and remains high in metastatic lesionsVilde Linnea Gullovsen, Daniela Pavlicenco, Marta E Hjelmeland, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 8, 2011
Evolution in endometrial cancer: evidence from an immunohistochemical studyIngrid Vandenput, Jone Trovik, Karin Leunen, et al.Pageof 14